CAS: 82857-40-7; N-Methyl-3-Phenyl-3-(O-Tolyloxy)Propan-1-Amine Hydrochloride

该化合物是一种选择性的肾上腺素再摄入抑制剂,主要用于药理研究与开发,作为亚多摩克丁的种族形式,它由(R)-和(S)-抗生素组成,为立体化学研究和比较功效评估提供了宝贵的参考标准.盐能提高溶性性和稳定性,促进配制和分析应用.该化合物对研究肾上腺...

结构式图片

MSDS等安全信息

    合成工艺路线路线简述

      海关参考信息

      专利信息


      专利号:US-7507861-B2
      优先权日:2004-06-28
      标题:Process for the preparation of atomoxetine hydrochloride
      发明人:CASTELLI EUGENIO; LO MONACO GIUSEPPE; MANTOVANI SILVIA; DAVERIO PAOLA; RIVA PAOLO; VAILATI ALESSANDRA; BIANCHI STEFANO
      权利人:TEVA PHARM FINE CHEMICALS SRL
      摘要:The present invention provides improved processes for the preparation of atomoxetine hydrochloride under reaction conditions that improve reaction yields and facilitate commercial synthesis. In particular, the invention is directed to the synthesis of atomoxetine HCl by adding HCl to a mixture of (R)-(−)-tomoxetine (S)-(+)-mandelate with an organic solvent, with or without a base and water.

      专利号:US-7439399-B2
      优先权日:2004-06-28
      标题:Processes for the preparation of atomoxetine hydrochloride
      发明人:ARONHIME JUDITH; BIANCHI STEFANO; CASTELLI EUGENIO; DAVERIO PAOLA; MANTOVANI SILVIA; KOVACSNE-MEZEI ADRIENNE
      权利人:TEVA PHARM FINE CHEMICALS SRL
      摘要:The present invention provides improved processes for the preparation of atomoxetine hydrochloride under reaction conditions that improve reaction yields and facilitate commercial synthesis. In particular, the invention is directed to the synthesis of atomoxetine HCl by adding HCl to a mixture of (R)-(−)-tomoxetine (S)-(+)-mandelate with an organic solvent, with or without a base and water. In preferred embodiments, the atomoxetine hydrochloride produced is Form A.

      专利号:EP-1673335-A2
      优先权日:2004-06-28
      标 题 :Process for the preparation of atomoxetine hydrochloride
      发明人:CASTELLI EUGENIO; LO MONACO GIUSEPPE; MANTOVANI SILVIA; DAVERIO PAOLA; RIVA PAOLA; BIANCHI STEFANO
      权利人:TEVA PHARM FINE CHEMICALS SRL
      摘要:The present invention provides improved processes for the preparation of atomoxetine hydrochloride under reaction conditions that improve reaction yields and facilitate commercial synthesis. In particular, the invention is directed to the synthesis of atomoxetine HC1 by adding HCl to a mixture of (R)-(-)-tomoxetine (S)-(+)­mandelate with an organic solvent, with or without a base and water.

      专利号:US-5510516-A
      优先权日:1990-07-06
      标 题 :Process for selective epoxidation of unsaturated (meth)acrylates, new functional (meth)acrylates obtained and their application to the synthesis of new polymers
      发明人:CAUBERE PAUL; FORT YVES; ORTAR AGNES
      权利人:ATOCHEM
      摘要:An unsaturated (meth) acrylic compound of formula: (I) (X=O, S, NH, NR3 (R3=C1-12-alkyl) or O-(CH2)n (where n=1-16 approximately); R2=C2-20 straight-chain or branched alkyl, monocyclic or polycyclic cycloalkyl or heterocycloalkyl, or alkylaryl hydrocarbon chain, comprising an olefinic double bond in the chain, or at the end of the chain in the case of alkyl or alkylaryl, or an exocyclic or endocyclic olefinic double bond in the case of monocyclic or polycyclic cycloalkyl or heterocycloalkyl; and R1=H or C1-5-alkyl), is reacted at 10 DEG -60 DEG C. with at least one oxidising compound (hydrogen peroxide) in the presence of at least one catalyst (alkali metal molybdates and tungstates) and in the presence of at least one phase transfer agent and when R2=polycyclic cycloalkyl or hetercycloalkyl, an organic peracid or hydrogen peroxide in the presence of at least one heteropolyacid. To open the epoxide function, the epoxide obtained is reacted with a compound chosen from strong inorganic acids, boron trifluoride etherate complexes, acid salts in the presence of the corresponding acid, halides of trialkylsilanes or trialkoxysilanes, and ketones in the presence of cationic resins.

      专利号:US-2008004470-A1
      优先权日:2004-09-27
      标 题:Synthesis of Atomoxetine Hydrochloride
      发明人:MATHAD VIJAYAVITTHAL T; GHANTA MAHESH R; GOVINDAN SHANMUGAM; MACHARLA PRABHAKAR; NALIVELA VENU
      权利人:MATHAD VIJAYAVITTHAL T; GHANTA MAHESH R; GOVINDAN SHANMUGAM; MACHARLA PRABHAKAR; NALIVELA VENU
      摘要:(±)-Atomoxetine oxalate having crystalline Form II and a solid (±)-atomoxetine free base are useful in preparing atomoxetine hydrochloride.

      专利号:WO-2008062473-A1
      优先权日:2006-10-31
      标 题 :Process for preparing atomoxetine hydrochloride
      发明人:PATEL VIPUL KANTIBHAI; KUMAR RAJIV; DHAR DWIVEDI SHRIPRAKASH
      权利人:CADILA HEALTHCARE LTD; PATEL VIPUL KANTIBHAI; KUMAR RAJIV; DHAR DWIVEDI SHRIPRAKASH
      摘要:The present invention relates to the process for preparing Atomoxetine hydrochloride which is a selective norepinephrine reuptake inhibitor. Atomoxetine HCl is chemically known as (-)-iV-Methyl-3-phenyl-3-(o-tolyloxy)-propylamine hydrochloride and represented by formula (I). More particularly, the invention relates to crystalline form of N-methyl-3-phenyl-3-(o- tolyloxy) propylamine oxalate (here in after referred as '(±) Atomoxetine Oxalate'), which is an useful intermediate for the synthesis of Atomoxetine hydrochloride.

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      主要参考文献


      1: Wong DT, Threlkeld PG, Best KL, Bymaster FP. A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain. J Pharmacol Exp Ther. 1982 Jul;222(1):61-5.

      合成参考文献


      参考文献:10.1186/s13065-023-00951-0
      摘要:Abu-Hassan AA. A novel spectrophotometric approach relies on a charge transfer complex between atomoxetine with quinone-based π-acceptor. Application to content uniformity test. BMC Chem. 2023 Apr 22;17(1):40.
      参考文献:10.1186/s13065-023-01094-y
      摘要:Abu-Hassan AA. Nano-level assay of attention-deficit/hyperactivity disorder medicament, atomoxetine by molecular-size-based resonance rayleigh scattering strategy. Employment in content uniformity, dosage form, and plasma analysis. BMC Chem. 2023 Dec 06;17(1):175.
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知